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Abstract 
The athletic nature of the horse and the large number of diverse horse breeds provides 
an opportunity to study the genetics of locomotion pattern and performance in 
mammals. The overall aim of this thesis was to get a better understanding of the 
genetics behind gaits and performance in the horse. This thesis compiles four papers on 
four different horse breeds. In studies I and II we describe the effect of a known 
mutation in the doublesex and mab-3 related transcription factor3 (DMRT3) gene on 
harness racing performance in Swedish-Norwegian Coldblooded trotters and 
Finnhorses. Previous studies have demonstrated a major impact of the gene on harness 
racing performance results in Standardbreds. While the gene clearly is important for 
harness racing performance in both Coldblooded trotters and Finnhorses, the most 
successful genotype differed between the two breeds. The homozygous mutant (AA) 
Finnhorses were most successful on the racetrack but had difficulties in performing a 
good canter in riding. For Coldblooded trotters the CA horses were the better race 
horses overall, even though the AA horses performed well at young ages.  
While previous studies have reported that homozygozity for the DMRT3 mutation 
(AA) is required for a horse to be able to pace, not all AA horses can pace. To 
understand more about the genetic regulation of pace, in study III we compared the 
genomes of AA Icelandic horses with and without the ability to pace. We performed a 
genome-wide association study and identified a potential candidate region that 
contained a gene known to influence memory and learning ability.  
In study IV we utilized the close relationship between the Coldblooded trotter and 
the North-Swedish draught horse to identify novel genes influencing harness racing 
performance. The two breeds are genetically similar but have been selected for 
different traits. By comparing the genomes of the two breeds with the genome of 
Standardbreds, we identified five top regions where the Coldblooded trotters and 
Standardbreds were similar but together differed from the North-Swedish draught 
horse. One of the regions identified contained five single nucleotide polymorphisms 
(SNPs) that were significantly associated with racing performance in Coldblooded 
trotters.  
In conclusion, this research shows that carefully selected horse materials can serve as 
models to gain deeper knowledge on the genetics of performance and locomotion 
pattern. It is also vital to contextualize the importance of these genes within each horse 
breed.  
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1 Introduction 
1.1 Horse domestication and breed creation 
Horses (Equus ferus caballus) have, since their domestication, played 
important roles in society, and today horses are kept for both business and 
pleasure. The exact time period for horse domestication has been debated, and 
many different time periods and locations have been proposed, with time 
suggestions ranging from the early Bronze Age (5000-3900 years Before 
Present [BP]) to the Neolithic Age (8000-6000 years BP) (Levine, 2005, 
Outram et al., 2009, Schubert et al., 2014). Since then and until about 100 
years ago horses were mainly used for transportation and warfare, but today 
most horses are kept for sport or recreation purposes (Levine, 2005). In some 
countries there is also a horsemeat industry (Martuzzi et al., 2001, Belaunzaran 
et al., 2015). While almost all existing horse breeds today are bred and 
controlled by humans, a few wild horse populations still exist. However, only 
one, the Przewalski´s horse (Equus ferus ssp. przewalskii), is a true wild horse 
that has never been domesticated (Goto et al., 2011). The Przewalski´s horse 
became extinct in the 1960´s but was bred in captivity and re-introduced to the 
wild in the beginning of the 1990´s (Ryder & Wedemeyer, 1982, Ryder, 1993, 
King, 2005). Today the Przewalski´s horse is listed as endangered with about 
2,000 individual horses present in the population (King et al., 2015). It is 
considered a subspecies of the wild horse (Equus ferus) and possesses 66 
chromosomes, compared to 64 in the modern horse (Benirschke et al., 1965, 
King et al., 2015). Due to this difference in chromosome number, the 
Przewalski´s horse is considered a sister taxon to the wild ancestors of 
domestic horses (Kavar & Dovč, 2008). A recent study suggested that the 
Przewalski´s horse and the domestic horse population split about 45,000 years 
ago (Der Sarkissian et al., 2015). While it is possible that domestic horses 
originate from one founder population, most research on horse origin using 
mitochondrial DNA (mtDNA) demonstrates that it is more likely that several 
distinct horse populations were involved in the domestication process (Lister et 
al., 1998, Vilá et al., 2001, Jansen et al., 2002, Lippold et al., 2011). The 
patrilineal diversity in domestic horses is significantly lower, likely due to the 
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use of a limited number of stallions in the breeding of the domestic horse 
(Lindgren et al., 2004, Kavar & Dovč, 2008, Wallner et al., 2017). Following 
domestication of the horse, selection and breeding of horses created a large 
number of diverse breeds. Today about 1,400 different horse breeds of various 
sizes, shapes and colors exist in the world, according to the Domestic Animal 
Diversity Information System database of the Food and Agriculture 
Organization of the United Nations (FAO) (FAOSTAT, 2017). However, there 
are likely duplicate breeds reported, as some breeds may have slightly different 
names in different countries. The different breeds are used for many diverse 
purposes, including agricultural work, jumping, racing, driving and exhibitions. 
According to FAO, in 2014, there were about 58 million horses in the world 
(FAOSTAT, 2017).  
1.2 Horse breeding 
As for the domestication time, it is difficult to determine exactly when humans 
started to breed horses, i.e. deliberately planning the breeding and keeping 
track of pedigrees. Today, a large proportion of the breeds are meticulously 
monitored in studbooks and the newborn foals are registered and marked, most 
often with a chip. Many breeding organizations also require hairsamples from 
newborn foals to be sent for parentage control. The studbooks for the breeds 
can be either open or closed. An open studbook means that the book is open for 
all horses that meet the breed specific requirements. A closed studbook only 
accepts horses where the parents are registered in the same studbook. While 
natural matings are still the most common reproduction method in many 
breeds, the use of artificial reproduction techniques such as artificial 
insemination (AI) and embryo transfer (ET), provide the opportunity to breed 
stallions and mares from different countries (Brinsko & Warner, 1992, Allen, 
2005, Hinrichs, 2013). Another reproduction technique that can be applied is 
cloning. By cloning it is possible to create an individual that is an exact genetic 
copy of the animal donor. The first mammal clone from an adult somatic cell 
was the sheep Dolly, which was cloned in 1996 and the first horse was cloned 
in 2003 (Campbell et al., 1996, Galli et al., 2003).  
1.2.1 Introduction of genetics and genomics into horse breeding 
Historically, the breeding and selection of horses was solely based on pedigree 
and appearance of the horses. Today, the use of genetic information is 
becoming more and more important in the breeding work. By sequencing an 
individual‟s genome, every base of the DNA (deoxyribonucleic acid) is 
charted. The first human was sequenced in 2001 (Lander et al., 2001) and the 
first horse genome sequenced was published in 2009 (Wade et al., 2009). Since 
then there has been a rapid development of new technologies and techniques 
within the field of genomics. This increase in the number of analysis tools 
available has resulted in a sharp reduction of the costs to analyze the genome. 
A classic example is the cost associated with sequencing the human genome. 
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The costs for the project in which the first human genome was sequenced and 
analyzed were approximately $300 million (Lander et al., 2001). Today, the 
cost for sequencing the mammalian genome (3x10
9
 base pairs [bp]) is getting 
close to a $1000 per sample (Wetterstrand, 2015). As a result, the possibilities 
for using genomic tools in the breeding of animals are growing each year. A lot 
of genomic horse research is being conducted all over the world, thus 
increasing the availability of commercial genetic tests for horse breeders to use 
in their work. Already today there are a number of genetic tests available, 
where breeders can test their horses for genetic variants associated with 
different genetic diseases, coat color and/or performance. Examples of tests 
available include the test for the eye defect multiple congenital ocular 
anomalies (MCOA) that is linked to the Silver coat color, and skeletal atavism 
in Shetland ponies (Andersson et al., 2011, Rafati et al., 2016). By testing the 
breeding animals, it is possible to avoid breeding two horses that are carriers of 
the same disease alleles, thus minimizing the risk of breeding affected 
offspring.  
1.3 Marker-assisted selection, genomic breeding values and 
genomic selection 
The use of traditional breeding methods, i.e. selection of the superior animals 
to produce offspring, has been successful for the genetic improvement in many 
ways. However, the efficiency of these methods is lower if traits are difficult to 
measure, if the heritability is low or if it is difficult or costly to measure many 
animals in a short period of time (Eggen, 2014). These traits include for 
example fertility and resistance to diseases (Eggen, 2014). To improve the 
breeding for these types of traits, the use of genomic information has become 
important (Eggen, 2014). In the beginning of the 1990´s the marker-assisted 
selection (MAS) technology was introduced. The concept is that instead of 
measuring the actual trait of interest, a marker (biological or DNA/RNA) that 
is known to be associated with the trait is measured and used to predict the 
phenotype (Eggen, 2014). However, the limitation of the MAS technology is 
that it requires prior knowledge about the markers that are used (Eggen, 2014).  
 
The first study that described the concept of genomic selection was published 
in 2001 (Meuwissen et al., 2001). The idea of genomic selection is that a large 
number of genetic markers (single nucleotide polymorphisms, SNPs) are used 
to select which animals should be used in breeding (Eggen, 2014). A reference 
population of animals with accurate phenotype records is genotyped for a large 
number of SNPs. Using the information from the reference group, genomic 
breeding values (GEBVs) can be estimated without having complete 
knowledge about the genes in the genome (Eggen, 2014). As a large number of 
SNPs are used in the estimation, it is assumed that there is at least one SNP in 
close linkage disequilibrium (LD) with the causative mutation (Goddard & 
Hayes, 2009, Eggen, 2014). Based on the prediction equation retrieved from 
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the reference population, GEBVs can then be calculated for another group of 
selection candidate animals that have been genotyped for the same SNPs but 
lack phenotype records (Goddard & Hayes, 2009, Eggen, 2014). Using 
genomic selection will improve the selection response and reduce the 
generation interval, especially when selecting for traits that are limited to one 
sex or traits that appear later in life (i.e. fertility) (Eggen, 2014). While the use 
of genomic selection is increasing one of the challenges is the need for a large 
reference population to accurately be able to estimate GEBVs, as well as the 
costs that comes with the genotyping (Goddard & Hayes, 2009).   
 
In horses the use of genomic selection is not very common, although it has 
been demonstrated to potentially reduce the generation interval in horse 
breeding programs (Haberland et al., 2012). As the accuracies of breeding 
values do not increase significantly until the offspring of a horse starts to 
compete, introducing genomic breeding values would improve the accuracies 
of the breeding values for young horses, especially for horses that do not have 
any competition data or offspring (Haberland et al., 2012). This will enable 
selection of horses at an earlier age, reducing the generation interval and 
potentially increasing the genetic progress of the breed (Haberland et al., 
2012).  
1.4 Monitoring inbreeding level 
An intensive selection for a specific trait, especially in combination with a 
small population size, may increase the level of inbreeding. Inbreeding (i.e. 
breeding of related individuals) can increase the risk of inheriting rare defects 
or diseases due to an increased homozygosity for rare recessive alleles. It may 
also lead to a loss of important genetic variants. Partly due to the heavy 
selection for performance, a significant increase in inbreeding level has been 
observed in several breeds, for example Thoroughbreds and Standardbreds 
(Árnason, 2011, Binns et al., 2011).  
 
Traditionally the individual inbreeding level has been estimated using pedigree 
information (Boyce, 1983). However, as the genetic relationship level may 
differ from the pedigree relationship level, to accurately estimate the 
inbreeding level in an individual, the estimation needs to be done on a genetic 
level. There are several different molecular tools available that can be used to 
analyze and monitor the genetic inbreeding level (Bruford et al., 2017).  
1.5 Trait definition, pleiotropy and inheritance patterns 
Within genetics, the traits or phenotypes can be classified into two different 
groups: monogenic or polygenic, depending on whether they are affected by a 
single gene or a combination of many genes. Monogenic traits, also referred to 
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as Mendelian traits, are explained by one gene with very little, if any, 
environmental impact. Polygenic traits on the other hand, also called 
multifactorial or complex traits, are influenced by a combination of several 
genes and environmental factors. As a result, polygenic traits are generally 
more difficult to study genetically compared to monogenic traits (Glazier et al., 
2002). Different traits can also be classified as qualitative and quantitative. A 
qualitative trait is categorized into discrete groups, for example blood groups 
(A, B, AB, 0). Quantitative traits show a continuous variation, for example 
length measurements. A large number of QTLs (quantitative trait locus) have 
been identified, but revealing the causative mutation is more challenging 
(Andersson, 2009). Despite this, there are examples of studies where the 
causative mutation, or QTN (quantitative trait nucleotide), for a complex trait 
has been identified (Grisart et al., 2002, Van Laere et al., 2003, Clop et al., 
2006).  
 
Some of the loci that have been identified in genetic studies show pleiotropic 
effects. This means that the same gene influences more than one phenotype. 
Some of the well-known pleiotropic associations are those between coat color 
and diseases (Reissmann & Ludwig, 2013). A few examples are the Silver coat 
color and the eye defect MCOA, the Grey coat color and melanoma, and the 
Overo coat color and Overo lethal white syndrome (OLWS) (Santschi et al., 
1998, Pielberg et al., 2008, Andersson et al., 2011).  
 
The inheritance patterns for different traits can be categorized into dominant or 
recessive and autosomal or X-linked. All organisms have two copies of each 
chromosome, one that it is inherited from the mother and one that is inherited 
from the father, and the chromosomes contain the individuals DNA 
(deoxyribonucleic acid). For a dominant inheritance pattern only one allele is 
required for the phenotype to be displayed. For a recessive inheritance pattern, 
two copies of the same allele are required for the phenotype to be displayed. If 
the inheritance pattern is autosomal or X-linked depends on whether the SNP is 
located on one of the autosomal chromosomes or on the X-chromosome. Many 
of the rare genetic diseases show a recessive inheritance pattern, which means 
that both parents need to be carriers of the genetic variant for the offspring to 
show the phenotype.  
1.6 Locomotion pattern of the horse 
The horse is an explosive and very athletic animal. For centuries humans have 
used horses for transportation and competitions. As a consequence, horses have 
long been selected for their locomotion pattern and gaits, and for many breeds 
the gaits are considered the most important features. All horses possess four 
different gaits: walk, trot, canter and gallop. These gaits are classified based on 
stride length, stride duration and speed (Barrey, 2013). In addition, a large 
number of breeds are also able to perform a variety of additional gaits, and 
16  
these breeds are referred to as “gaited” or sometimes “ambling” horse breeds. 
There are about 80 gaited breeds in the world and these breeds can perform 
many different, often breed-specific, gaits. The majority of the alternative gaits 
are classified as ambling gaits, and some breeds also have the ability to 
perform the lateral gait pace (Barrey, 2013).  
1.6.1 Definition of the gaits 
The gaits of a horse can be defined as a coordinated rhythmic movement of 
both the limbs and the body, which together produces forces for movement 
(Barrey, 1999). The definition of a stride is a full cycle of limb movement 
(Barrey, 1999). There is no clear beginning or end of a stride as it is a 
continuously repeated pattern. A complete limb cycle includes a stance phase 
and a swing phase (Barrey, 1999). The stance phase is when the limb is in 
contact with the ground and the swing phase is when the hoof is lifted up from 
the ground (Barrey, 1999).  
 
All gaits can be divided into either symmetrical or asymmetrical depending on 
whether the limbs are considered to be used equivalently or if they are 
employed differently (i.e. if there is symmetry between the left and right sides 
or not) (Barrey, 1999, Robilliard et al., 2007, Barrey, 2013). The symmetrical 
gaits include walk, trot, tölt and pace, while canter and gallop are considered 
asymmetrical gaits (Barrey, 1999, Robilliard et al., 2007, Barrey, 2013). 
Another way of classifying gaits is to divide them into stepping/walking gaits 
and running gaits (Barrey, 2013). The difference between the stepping/walking 
gaits and the running gaits is that for walking gaits there is always at least one 
foot in contact with the ground. For the running gaits there is at least one 
suspension phase in each stride, when no foot is in contact with the ground 
(Barrey, 2013).  
 
Walk is the slowest gait, it is a four-beat gait with no suspension and with a 
speed of approximately 1.2-1.8 meters per second (m/s), corresponding to 4.5-
6.5 kilometers per hour (km/h) (Barrey, 2013). Other examples of walking 
gaits are tölt, paso, running walk and stepping pace, which are performed at 
speed varying between 3.4 and 5.3 m/s, equivalent to 12-19 km/h (Barrey, 
2013). The running gaits can be divided into trot, pace, canter and gallop. The 
trot is a two-beat diagonal gait, with a speed of 2.8-14.2 m/s, or 10-50 km/h 
(Barrey, 2013). Pace is a lateral symmetric gait, where the horse moves the 
legs at the same side of the body at the same time. The speed of pace can vary 
between 9 and 16m/s, or 32-58 km/h (Barrey, 2013). The higher speed 
obtained in pace compared to trot is likely due to fewer coordination problems 
in the pace, as there is less problem of limb interference compared to the trot 
(Barrey, 2013). Canter and gallop are two descriptions of the same asymmetric 
gait, performed at different speeds. The canter is a slower three-beat gait, while 
the increase in speed makes the gait four-beat (Barrey, 2013). Gallop is the 
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fastest gait a horse can perform with a speed of up to 20 m/s, equivalent to 72 
km/h (Barrey, 2013).  
1.6.2 Assessment of locomotion pattern and gaits in horses 
Gaits and locomotion pattern are considered very important traits for many 
breeds and the gaits are often evaluated at competitions and breeding shows. 
Assessment of locomotion pattern in horses is traditionally done by having one 
or more persons visually evaluating the horse and scoring the different gaits. 
Although some people are very good in evaluating horses, it is still a subjective 
evaluation. As such, the evaluation is influenced by a number of external 
factors, for example the experience of the person evaluating the horse and the 
environment where the evaluation takes place (Parkes et al., 2009, Clayton & 
Schamhardt, 2013). Also, by judging a horse visually it can be difficult to 
observe small differences or changes in gait pattern, especially at higher 
speeds. Therefore the use of different objective measuring-techniques is 
becoming more common to overcome these obstacles and increase the 
accuracy of the locomotion pattern evaluation.  
 
Traditionally, studies of locomotion pattern in horses are performed using two 
different approaches: kinetics and kinematics (Barrey, 1999). Kinetics is a 
concept that involves the study of forces (i.e. causes of motion). Kinematics, 
on the other hand, focuses on velocity and acceleration (i.e. motion changes). It 
includes measures of timing, distance and angles (Barrey, 1999, Clayton & 
Schamhardt, 2013). The first kinetic study that used sensors to measure the 
forces of the hooves in different gaits was performed in 1873. Even though the 
techniques have developed since then, we still today, almost 150 years later, 
use the same measurement principles of the gaits (Marey, 1873, Barrey, 1999). 
For kinematic studies a common approach is to film the horses in movement. 
Already in 1887 the first kinematic study was performed, by using 
chronophotography (Muybridge, 1887).  
 
For locomotion analysis in horses there are a number of different techniques 
available. For kinetic studies one important concept is the ground reaction 
force (GRF) (Clayton & Schamhardt, 2013). The GRF is the force that is 
exerted back from the ground during the stance phase of a stride, when the 
hoof is put down on the ground. The magnitude of the GRF is the same as the 
force from the hoof, and the GRF is described by its magnitude, direction and 
point of application (Clayton & Schamhardt, 2013). The force from the hoof 
can be divided into three different force components that act in a vertical, 
longitudinal or transverse direction (Clayton & Schamhardt, 2013). The GRF 
can be measured using either a force plate or force shoes (Clayton & 
Schamhardt, 2013). Other instruments used in kinetic studies to measure the 
transmission of forces and accelerations through the body are strain 
transducers, ultrasonic transducers, accelerometers, gyroscopes and 
magnetometers attached to the segment (Clayton & Schamhardt, 2013).  
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For kinematic studies one common method used involves optical motion 
capture (Clayton & Schamhardt, 2013). It is based on markers that are attached 
to the skin or the bones of the horses, mainly on the legs and back, and then the 
horses are filmed (Barrey, 1999, Clayton & Schamhardt, 2013). There are three 
different types of marker-methods used: passive markers, active markers or 
marker-less methods (Clayton & Schamhardt, 2013). The passive markers are 
made of a reflective material that will reflect light, while the active markers are 
usually LED lights that are flashed in different patterns. The marker-less 
method uses a pattern of recognition software to track the area of interest 
(Clayton & Schamhardt, 2013). By using the optical motion capture it is 
possible to make animations and perform gait analysis. To perform this kind of 
studies multiple cameras are needed to record the activity, especially to get 
three-dimensional models (Clayton & Schamhardt, 2013). Therefore, these 
kinds of studies are mainly performed in laboratory environments (Clayton & 
Schamhardt, 2013).  
 
For studies outside the laboratory the wireless sensor technique can be used. 
Small sensors are attached to different parts of the horse‟s body and with the 
help of accelerometers and transducers signals are transferred to a computer 
where the data can be analyzed. The first study that used a wire-less sensor 
system for gait analysis was performed in 1994 (Barrey et al., 1994). With the 
wireless sensor system it is possible to evaluate the gaits not only on a 
treadmill but also in the field on different ground surfaces (Clayton & 
Schamhardt, 2013). The treadmill is a very good and useful tool for gait 
analysis as it is possible to control both speed and the surrounding 
environment. However, studies have demonstrated differences in the stride 
kinematics on a treadmill compared to ground locomotion, and with the wire-
less systems these differences can be accounted for (Barrey et al., 1993, 
Buchner et al., 1994). The results from sensor-based systems are comparable 
with the results from the video-based motion analysis systems and the systems 
can accurately capture most of the variation in head nod hip hike and back 
movement. Despite that it is important to be aware of the limitations that exists 
when it comes to accuracy, precision and repeatability (Keegan et al., 2004, 
2011, Warner et al., 2009, Pfau et al., 2016a, 2016b). 
 
Most gait analysis systems today are used to evaluate lameness in horses. 
Several studies have shown that the agreement between veterinarians visually 
examining mildly lame horses is low, and the agreement level is affected by 
the experience levels of the veterinarians (Keegan et al., 1998, 2010, 
Hammarberg et al., 2016). Also, the lameness score differed depending on 
which type of scoring system that was used (Hewetson et al., 2006). In 
addition, one study reported movement asymmetries also in horses perceived 
as free from lameness by their owners (Rhodin et al., 2017). As such, even 
though there are some limitations of the sensor systems used, the use of the 
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objective evaluation systems make it easier to detect the mechanical changes 
that occur in lame horses (Pfau et al., 2016a). In addition to lameness 
evaluation, the evaluation of locomotion pattern is useful also for prediction of 
performance in horses (Barrey, 1999). Studies have demonstrated that the 
pattern of locomotion influences performance in different disciplines and this 
information could for example be used to predict the potential performance 
ability in young horses (Deuel & Park, 1991, 1993, Barrey et al., 1995, Barrey 
& Galloux, 1997, Barrey, 1999).  
1.7 The DMRT3 mutation – a single base change with major 
impact on a complex trait 
1.7.1 Identification of the “Gait Keeper” mutation in horses 
Locomotion pattern and performance are complex traits influenced by both 
genes and environment. Therefore the findings from a genome-wide 
association study (GWAS) on pacing ability in Icelandic horses were quite 
amazing (Andersson et al., 2012). The study compared Icelandic horses that 
were four-gaited (walk, trot, canter, tölt) and five-gaited (walk, trot, canter, 
tölt, pace) using the 50K Equine SNP chip array. Tölt is a four-beat ambling 
gait while the pace is a two-beat lateral gait. The results revealed one 
significant SNP on equine chromosome 23 (Chr23:22,967,656). By sequencing 
additional horses with different gait pattern, the causative mutation was 
identified (Chr23:22,999,655). The mutation, a change from cytosine (C) to 
adenine (A), was located in the second exon of the doublesex and mab-3 
related transcription factor3 (DMRT3) gene (Andersson et al., 2012). It 
introduces a stop codon and results in a truncated protein lacking 174 amino 
acids (about 40%) of the normal protein (Andersson et al., 2012). While all 
gaited horse breeds analyzed were either homozygous mutant (AA) or 
heterozygous (CA), most of the horses considered to be non-gaited (i.e. with 
only walk, trot, canter and gallop) were homozygous for the wild-type allele 
(CC) (Andersson et al., 2012). Interestingly, the frequency of the homozygous 
mutant genotype (AA) was high in Standardbreds, a breed used for harness 
racing. This suggested that there was an effect of the gene also on the ability to 
trot in high speed. Further investigation of the association between the 
mutation and harness racing performance demonstrated a significant impact of 
the gene on both racing performance traits and trotting technique in 
Standardbreds (Andersson et al., 2012)  
1.7.2 Characteristics of the DMRT3 gene and its encoded protein 
In addition to the effects on locomotion pattern in horses, the DMRT3 protein 
was found to be critical for development of a normal locomotor network in 
mice (Andersson et al., 2012). The DMRT3 gene is a member of the doublesex 
and mab-3 related transcription factor gene family, which includes eight 
different DMRT genes (1-8) mainly involved in sexual development (Hong et 
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al., 2007). As a transcription factor, the DMRT3 protein is involved in 
regulating the transcription by binding to specific DMRT3 binding sites at 
regulatory DNA sequences (Latchman, 1997, Murphy et al., 2007). The DMRT 
genes all share a conserved cysteine-rich DNA binding motif called the DM 
domain, but except for that they show little sequence conservation (Raymond 
et al., 1998, Murphy et al., 2007, Kopp, 2012). The DM domain is a zinc-
finger like DNA binding motif that interact mainly with the minor groove of 
the DNA (Zhu et al., 2000, Murphy et al., 2007). The DMRT proteins can bind 
DNA as heterodimers, and sometimes the heterodimer binding is even more 
efficient than the binding of the homodimer (Murphy et al., 2007). In mice and 
chicken embryos the DMRT3 gene is mainly expressed in forebrain, neural 
tube and nasal placode but it is also expressed in mice testes and ovaries 
(Smith et al., 2002, Kim et al., 2003). Like the other DMRT genes the DMRT3 
gene has been suggested to be involved in sexual development, and some male 
mice from a DMRT3 knockout model demonstrated sexual development 
abnormalities (Kim et al., 2003). Interestingly, the null mice also displayed 
shorter lifespan due to dental problems, compared to the wild-type mice 
(Ahituv et al., 2007). Although there have been several studies that 
demonstrated where the DMRT3 gene is expressed and how it influences 
locomotion pattern, which genes that are targeted by the DMRT3 protein is still 
unknown.  
 
In mammals the DMRT3 gene is expressed in the dI6 subdivision of spinal cord 
neurons. These are inhibitory neurons that cross the midline of the spinal cord, 
so called commissural neurons, which can synapse onto motor neurons 
(Andersson et al., 2012). The neurons are involved in neuronal circuits or 
networks referred to as central pattern generators (CPGs) (Kiehn, 2006, 
Goulding, 2009, Nishimaru & Kakizaki, 2009, Dyck et al., 2012, Vallstedt & 
Kullander, 2013). These networks are responsible for the output patterns 
required for movement, by controlling the timing and pattern of muscle 
contractions (Kiehn, 2006, Nishimaru & Kakizaki, 2009, Dyck et al., 2012). 
There are five different classes of neurons present in the ventral spinal cord, 
including the dI6 neurons (Dyck et al., 2012), and those can further be divided 
into different subpopulations (Goulding, 2009). The activity of the CPGs in the 
spinal cord is regulated by locomotor commands that originate from neurons in 
the brainstem and midbrain, and the CPGs have the ability to function without 
any sensory inputs (Kiehn, 2006, Goulding et al., 2009). The CPGs are 
important for a large part of the motor neuron activity that is crucial for a 
number of different body functions (Nishimaru & Kakizaki, 2009).  
 
Recent studies have demonstrated the importance of the DMRT3 gene in 
locomotion pattern control (Andersson et al., 2012, Larhammar, 2014, Perry, 
2016). Silencing of the gene created mice with impaired coordination of 
movements, alterations in gaits and difficulties coordinating left-right 
alternations (Andersson et al., 2012, Larhammar, 2014, Perry, 2016). In null 
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mice the output signal from the CPG was uncoordinated and had an irregular 
rhythm (Andersson et al., 2012). Also, the DMRT3 knockout mice displayed 
major difficulties to run at high speed and they demonstrated significantly 
longer stride lengths compared to control mice (Andersson et al., 2012). Later 
studies further characterized the importance of the DMRT3 gene for 
locomotion pattern and showed that the gene is critical for the development of 
dI6 neurons (Larhammar, 2014, Perry, 2016).  
 
Although the size of the dI6 subset of neurons did not differ between wild-type 
and null mice, the null mice had fewer commissural neurons and they 
displayed an increase of Wilm´s Tumor 1 (WT1) positive neurons that also 
belong to the dI6 interneurons. In addition, when DMRT3 was deleted in the 
mice there was an increase in the expression of DMRT1 (Andersson et al., 
2012). By analyzing spinal cord tissue from horses, Andersson et al. (2012) 
demonstrated that DMRT3 mRNA (messenger RNA) was present in both wild-
type and mutant horses, in a similar pattern as in mice. The DNA binding 
capacity of the protein was not affected by the mutation but the interaction with 
other protein/s may be defective (Andersson et al., 2012). 
1.7.3 The origin of the DMRT3 mutation in horses 
Recent research has focused on identifying when and where the DMRT3 
mutation first arose in horses (Wutke et al., 2016, Staiger et al., 2017). One 
study suggested, based on the DMRT3 genotype findings in ancient DNA, that 
the origin of gaitedness goes back to approximately 2900-2850 years BP in the 
medieval England (Wutke et al., 2016). From the Brittish Isles the ambling 
horses would then have spread to Iceland, likely around the 900´s (Wutke et 
al., 2016). A later study on 69 different horse breeds suggested, based on the 
low diversity in sequences from mutant chromosomes, that it is likely that the 
mutant DMRT3 chromosomes arise from a common ancestral sequence, no 
later than 10,000 years ago (Staiger et al., 2017). As such, the mutation 
probably occurred sometime around the time of the domestication of the horse, 
and then spread around the world (Staiger et al., 2017). The study also 
suggested that the DMRT3 nonsense mutation is causal, as no other sequence 
polymorphisms encompassing the DMRT3 gene showed stronger associations 
with the locomotion traits (Staiger et al., 2017). While the mutation is present 
in ancient horse DNA from as early as 2900 years BP, none of the wild-horse 
populations genotyped have been carriers of the mutation (Promerová et al., 
2014, Staiger et al., 2017).   
1.7.4 The frequency and the effect of the DMRT3 mutation in different horse 
breeds 
As demonstrated in several studies the frequency of the mutated A-allele is 
high in all of the gaited horse breeds (Andersson et al., 2012, Promerová et al., 
2014). On the other hand, in breeds classified as non-gaited almost all horses 
were homozygous wild-type (CC) (Andersson et al., 2012, Promerová et al., 
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2014). This suggests not only a favorable effect of the mutation on ambling 
and lateral gaits, but it also indicates a possible negative effect of the mutation 
on the basic gaits walk, trot and canter. Indications of the negative association 
between the DMRT3 mutation and the basic gaits have been demonstrated in 
several different breeds (Andersson et al., 2012, Kristjansson et al., 2014, 
Jäderkvist et al., 2015, Jäderkvist Fegraeus et al., 2015).  
1.7.4.1 Standardbreds 
The Standardbred is the major horse breed used for harness racing in the world 
(Figure 1). It has been bred for racing, trotting or pacing, for many generations 
and they are found in many countries in the world, including The United 
States, Canada, France, Sweden, Norway, Finland, Italy and Spain 
(Thiruvenkadan et al., 2009). As demonstrated in the study by Andersson et al. 
(2012) the mutation in DMRT3 affects the horses‟ ability to perform a clean, 
well-synchronized trot at high speed (Andersson et al., 2012). As a 
consequence, the large majority of Standardbreds are homozygous AA, and the 
frequency of the mutated allele appears to have been stable for at least 60 years 
(Andersson et al., 2012, Jäderkvist et al., 2014a, Promerová et al., 2014). 
While the American Standardbreds are fixed for the mutation, the frequency of 
the C-allele is significantly higher in the French trotter. It has even been 
suggested that the CA genotype is favorable for performance at older ages in 
this breed (Promerová et al., 2014, Ricard, 2015). The difference in genotype 
frequency observed between the French trotters and Standardbreds from other 
countries may be due to selection for slightly different attributes as there are 
differences in race types and regulations between the countries.  
 
 
Figure 1. A Standardbred trotter. Photo: Robert Fegraeus 
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The DMRT3 mutation allows the horses to race at high speed either in trot or 
pace, without transitioning in to gallop, which would be the natural gait in 
higher speeds in wild-type horses (Andersson et al., 2012). As a result, 
Standardbreds homozygous for the mutation performs significantly better at the 
racetrack compared to CA and CC horses, with higher earnings and faster 
times (Andersson et al., 2012, Jäderkvist et al., 2014a). In the United States 
Standardbreds are used for either pace or trotting races and the mutation is 
fixed in the American population (Promerová et al., 2014). Recent research has 
identified 7 SNPs that can be used to genetically differentiate a Standardbred 
trotter from a Standardbred pacer (McCoy et al., 2017). Many Standardbreds 
can also be difficult to use for riding, like show jumping or dressage, due to 
their difficulties at the canter. A study on Swedish Standardbreds demonstrated 
significant differences in riding ability traits between homozygous AA and 
heterozygous CA horses (Jäderkvist et al., 2015).  
1.7.4.2 Coldblooded trotters and Finnhorses 
The Swedish-Norwegian Coldblooded trotter is a breed originating from the 
North-Swedish horse and the Norwegian Döle horse (Figure 2) (Bohlin & 
Rönningen, 1975, Thiruvenkadan et al., 2009). While North-Swedish horses 
were mainly used for agricultural and forestry work, the Coldblooded trotters 
have been strictly selected for harness racing throughout the last century. This 
has created a breed with the appearance of a light draught horse but with a 
mentality more similar to Standardbreds. As the DMRT3 mutation was shown 
to strongly influence performance in Standardbreds, the hypothesis has been 
that the same genotype would also be favorable in the Coldblooded trotters 
(Andersson et al., 2012). A study in 2014 demonstrated a significant favorable 
effect of the AA genotype on performance at 3 years of age, with significantly 
higher earnings, more wins and placings as well as faster race times, compared 
to CA and CC horses (Jäderkvist et al., 2014a). However, at older ages, there 
were few significant differences between the genotypes, and it was even 
suggested that the CA horses would earn more money (Jäderkvist et al., 
2014a). Also, unlike in Standardbreds, no effects of the DMRT3 mutation on 
riding ability traits were observed in the Coldblooded trotters (Jäderkvist et al., 
2015). As the previous study on performance in Coldblooded trotters only 
included about 170 horses and the results suggested that the CA horses might 
earn more money at older ages, we have investigated the effect of the DMRT3 
mutation in a larger sample of raced and unraced Coldblooded trotters (Study 
I).  
 
24  
 
Figure 2. A Coldblooded trotter. Photo: Robert Fegraeus 
 
Another, phenotypically similar but genetically different breed to the Swedish-
Norwegian Coldblooded trotters is the Finnish Coldblooded trotter, the 
Finnhorse. There are four different types of Finnhorses: the trotting type, the 
riding type, a miniature type and a draught horse type (Figure 3). It is allowed 
to cross the different types, and the majority of the horses are used for harness 
racing (Hippos, 2017). To further understand the effects and the function of the 
DMRT3 gene we investigated the frequency of the DMRT3 mutation in a 
cohort of Finnhorses either used for harness racing or traditional riding (Study 
II).  
 
 
Figure 3. Finnhorses of different types. a) Trotter b) Riding horse c) Miniature 
d) Draught horse. Photo: Johanna Rautio/Wikimedia Commons 
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1.7.4.3 Icelandic horses 
The Icelandic horse is the only horse breed present in Iceland (Figure 4). Most 
Icelandic horses are either four-gaited (walk, trot, canter and tölt) or five-gaited 
(walk, trot, canter, tölt and pace). While the five-gaited horses exclusively are 
homozygous (AA) for the nonsense mutation in DMRT3, most four-gaited 
horses are heterozygous CA or homozygous CC (Andersson et al., 2012,  
Kristjansson et al., 2014, Jäderkvist et al., 2015). In concordance with studies 
on other breeds the DMRT3 mutation appears to not only influence gaiting 
ability, but also the quality of the gaits in Icelandic horses. Recent studies have 
demonstrated favorable effects of the AA genotype on breeding evaluation 
scores for tölt. However, the CA genotype was favorable for the evaluation 
scores for the basic gaits walk, trot and canter (Andersson et al., 2012, 
Kristjansson et al., 2014).  
 
 
Figure 4. An Icelandic horse in tölt. Photo: Wikimedia Commons 
 
Despite the strong association between DMRT3 genotype and number of gaits 
in Icelandic horses, the DMRT3 gene does not provide a complete explanation 
for the phenotypic variation observed. While the mutation undoubtedly is 
important for the ability to pace, not all AA horses pace (Andersson et al., 
2012, Kristjansson et al., 2014, Jäderkvist et al., 2015). As for all other 
complex traits the environment plays an important role, for example training of 
the horses, but it is also highly likely that other genes have an influence. 
Therefore, in this thesis we have investigated the genetic differences between 
four- and five-gaited Icelandic horses homozygous for the DMRT3 mutation 
(AA) (Study III). 
  
The gait tölt is the most important trait in Icelandic horse breeding evaluation 
(FEIF, 2017) and it is highly valued by both breeders and owners. Five-gaited 
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horses have been favored in breeding, which is reflected by the increase of the 
A-allele in the population during the last 30 years (Kristjansson et al., 2014). 
As previously reported, the DMRT3 gene influences the quality of Icelandic 
horse gaits and one study also showed an effect of the mutation on the ability 
to learn how to tölt. In addition, the DMRT3 gene appears to influence which 
gaits the horses chose on pasture and under saddle (Jäderkvist et al., 2015). 
The CC Icelandic horses were significantly more difficult to teach to tölt, and 
there are several examples of CC Icelandic horses that are classified as three-
gaited (i.e. they lack the ability to perform any kind of ambling gaits). 
Although three-gaited Icelandic horses exist in the population they are not very 
common, and the fact that some CC Icelandic horses are able to tölt is 
noteworthy. Especially since very few CC horses of other breeds are able to 
perform any alternative gaits (Andersson et al., 2012, Promerová et al., 2014). 
On the other hand, the lack of alternative gaits in CC horses of other breeds 
may also be due to lack of training for the particular gaits. The ability of some 
CC Icelandic horses to perform tölt is likely due to other genes under selection 
that favors lateral gaits, as the Icelandic horses have been bred for tölt for 
thousands of years. Also, intensive training for gait performance increases the 
likelihood that the horse will be able to perform the gait.  
1.7.4.4 Other gaited horse breeds 
Since the discovery of the mutation in 2012 a number of studies have 
investigated the frequency and the effect of the DMRT3 mutation in different 
breeds (Andersson et al., 2012). Many of the gaited breeds are fixed for the 
mutation, but there are a number of breeds where the mutation segregates and 
thus it is possible to investigate the effect of the mutation on the variation in 
gait pattern. The association of the DMRT3 mutation with gaiting ability has 
been demonstrated in breeds such as the Mangalarga Marchador, American 
Saddlebreds, Tennessee Walkers, American Curly and Morgan horses as well 
as a number of Chinese horse breeds (Jäderkvist et al., 2014b, Han et al., 2015, 
Patterson et al., 2015, Regatieri et al., 2016, Staiger et al., 2016). The studies 
demonstrated that while there is no doubt that the DMRT3 mutation is 
important for gaiting ability, there are clearly other genetic factors influencing 
the gaits (Jäderkvist et al., 2014b, Han et al., 2015, Patterson et al., 2015, 
Regatieri et al., 2016, Staiger et al., 2016, Fonseca et al., 2017).  
1.8 Other known genes influencing performance in horses 
1.8.1 Performance genes 
In addition to DMRT3 there are other genes known to influence performance in 
horses. Many studies on performance have focused on racing breeds, and 
several candidate genes have been identified. These include the creatine 
kinase, muscle (CKM), the cytochrome c oxidase, subunit 4, isoform 2 
(COX4I2), the sarcomeric α-actinin 3 (ACTN3), Myostatin (MSTN) and the 
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Pyruvate dehydrogenase kinase, isozyme 4 (PDK4) genes (Gu et al., 2010, Hill 
et al., 2010a, 2010b, Thomas et al., 2014). A large number of candidate genes 
important for performance also exist in humans (Schröder et al., 2011). 
Although potential performance genes have already been identified in horses, 
they do not explain all of the phenotypic variation observed. Performance is a 
complex trait influenced by a combination of genes and environmental factors. 
Therefore, in this thesis we have performed a genome scan of Standardbreds, 
Coldblooded trotters and North-Swedish draught horses with the aim to 
identify novel genes important for harness racing performance (Study IV).   
1.8.2 The influence of MSTN on performance 
One of the performance genes that has been thoroughly studied in horses 
during the last few years, particularly in Thoroughbreds, is the MSTN gene 
(Binns et al., 2010, Dall´Olio et al., 2010, 2014a, 2014b, Hill et al., 2010a, 
2010c, Tozaki et al., 2010, 2011a, 2011b, McGivney et al., 2012, Petersen et 
al., 2014, Velie et al., 2015, François et al., 2016). MSTN is located on the 
equine chromosome 18 (ECA18) and the protein is a member of the 
transforming growth factor β family. The gene is expressed in skeletal muscle, 
and it is involved in the regulation of skeletal muscle growth (McPherron et al., 
1997). In horses the gene has been associated with variations in body 
composition and conformation as well as competition performance and best 
racing distance in Thoroughbreds (Binns et al., 2010, Dall´Olio et al., 2010, 
2014b, Hill et al., 2010a, Tozaki et al., 2010, 2011a, 2011b, Santagostino et 
al., 2015, François et al., 2016). A number of genetic variants have been 
reported in the horse MSTN, although none with such dramatic phenotypic 
effects as observed for knockout mutations in other species (Grobet et al., 
1997, McPherron & Lee, 1997, Mosher et al., 2007).  
 
Previous studies on best racing distance and performance in Thoroughbreds 
have reported a strong association with a SNP (C>T) in one of the introns of 
MSTN (Hill et al., 2010a, 2010c). However, more recent studies suggests that 
an insertion of an Equine Repetitive Element (ERE1) retrotransposon in the 
promotor region of MSTN is the genetic variant that is targeted by the selection 
for short-distance racing (Petersen et al., 2014, Santagostino et al., 2015). This 
insertion is in LD with the previously reported SNP, and it influences the gene 
expression of MSTN (Hill et al., 2010a, 2010c, Santagostino et al., 2015). The 
insertion is associated with an increased proportion of type 2B muscle fibers 
and the frequency is high in horses used for short-distance races (Petersen et 
al., 2013, 2014, Santagostino et al., 2015).  
1.8.3 Epistatic regulation and breed specific gene effects 
As demonstrated in several studies, the gaiting phenotypes differ between 
breeds and not all horses with the DMRT3 mutation perform alternative gaits. 
This is partly due to environmental factors but it also strongly indicates an 
epistatic gene regulation. Epistatic gene regulation, or epistasis, is a 
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phenomenon where one gene influences the expression of other genes (i.e. 
gene interactions) (Phillips, 2008). This is for example the case with coat color 
in animals, where one gene variant may inhibit the activation/phenotypic effect 
of other genes, creating different coat colors or pattern (Phillips, 2008). Also, 
the effect of the genes may vary between different breeds, either due to genetic 
background or epistasis.  
1.9 Genetic methods to study gaits and performance in horses 
To better understand which genetic factors influence locomotion pattern and 
athletic performance in horses we have a wide variety of genetic tools to use. 
Depending on whether a candidate region is known or not there are different 
approaches used. If there is a gene with known functions, one can focus the 
study on that specific gene in order to investigate potential associations with 
other similar traits. However, for many genes there is limited knowledge about 
the function, and another approach is therefore necessary. Consequently, for 
many studies, especially studies on complex traits, the initial step is to perform 
association studies using a large number of genetic markers spread over the 
whole genome. If an association is detected between the trait of interest and 
any of the markers, this is usually followed up and verified in additional 
samples with the aim to identify the causative mutation. Once the mutation is 
known, functional studies are performed to determine how the mutation 
influences the phenotype of interest.  
1.9.1 Genome-wide association studies (GWAS) 
Genome-wide association studies were implemented in the beginning of the 
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 century as a way to identify genetic risk factors for different traits (Bush & 
Moore, 2012). To perform a GWAS two things are required: a sample set with 
genetic variation and a variable phenotype. The genetic variation is due to 
mutations in the form of SNPs, insertions, deletions or inversions of one or 
several nucleotides. For GWA studies SNPs are traditionally used. A SNP is 
the specific nucleotide position in the genome, where individuals or 
chromosomes differ from each other (i.e. where there are different nucleotides 
present in the DNA sequence). To be classified as a SNP the frequency of the 
minor allele should be higher than 1% (Brookes, 1999). SNPs are abundant in 
the genome and there are more than 23 million SNPs in the horse genome 
(Schaefer et al., 2017).  
 
The basic concept of GWAS relies on the assumption that SNPs are in LD with 
SNPs affecting disease or other phenotypes (Bush & Moore, 2012). LD simply 
means that there is a non-random association of alleles at two or more different 
loci (Slatkin, 2008). Recombination events that occur during meiosis break 
down LD and the LD between SNPs can be affected by selection, gene flow, 
genetic drift as well as mutations (Slatkin, 2008). When performing a GWAS 
all samples are genotyped for a large number of SNPs. The exact number of 
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SNPs used for GWAS studies varies between species but in horse there are 
SNP arrays available for 50,000 up to 2,000,000 SNPs (McCue et al., 2012, 
Schaefer et al., 2017). All SNPs are analyzed simultaneously for association 
with the phenotype of interest, either case-control differences (categorical 
phenotypes) or a quantitative measure (Bush & Moore, 2012). It is usually 
preferred to analyze quantitative measures as this gives more power to the 
analysis and it increases the possibilities to find a significant association (Bush 
& Moore, 2012). As not all SNPs in the genome are analyzed, most GWAS do 
not reveal the actual causative mutation, but more often SNPs that are in LD 
with a causative mutation. The results of a GWAS will be influenced by a 
number of factors such as sample size, SNP density and effect size of the 
mutation. Another important factor that may influence the results and that can 
cause false positive associations, is population stratification. When a 
population is divided into different groups it is possible to find associations 
between the phenotype of interest and SNPs that do not have any linkage to a 
causative mutation. In a GWA comparing horses with and without a disease 
there is a chance that the horses that have the disease are related and therefore 
share a larger proportion of the genotypes. A quantile-quantile (QQ) plot can 
be used to visualize population stratification, by plotting the observed versus 
the expected P-values for the association analysis. If the distributions 
compared are identical the plot will follow a 45° line indicating that there are 
no significant associations present.  
 
Also, when performing a large number of association tests it is important to 
correct for multiple-testing. For each association test performed the likelihood 
of obtaining a false positive association is 5 % (provided a P-value of <0.05). 
This can be corrected for using the bonferroni-correction where the P-value is 
divided by the number of association tests. An example is shown in study III 
where 670,000 SNPs were used and the P-value threshold was <0.05, yet the 
bonferroni corrected P-value was 0.05/670,000=7.4x10
-8
. Although often used 
in GWAS, one limitation of the bonferroni-correction is that it assumes that all 
tests are independent. In GWAS this is not usually the case as many markers 
will be in LD. As such, bonferroni is often considered too stringent for GWA 
analysis. Another way to correct for multiple testing is to use permutations. 
This method was used in the GWAS performed in study III in the current 
thesis. The permutation test is performed by randomly assigning the samples as 
cases or and controls and observing how often you get a P-value lower than the 
P-value observed is the association analysis. Most often a P-value less than 
0.05 is considered significant, and the number of permutations required varies 
between from 10,000 up to 1,000,000 depending on the size of the expected P-
value.  
1.9.2 Identity-by-descent (IBD) mapping, single SNP genotyping and 
association analysis 
A GWAS is usually the first step towards identifying novel genes with 
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influence on a specific phenotype. When a region has been identified as 
associated with a phenotype the next step is to follow up and narrow down the 
region in other horses. As all individuals in a population derive from common 
ancestors they will share some segments of their genome, so called identity-by-
state (IBD) regions. During meiosis the IBD segments will be broken up during 
the recombination process, and for each generation the IBD segments will 
become shorter. IBD-mapping can be used to identify the causative mutation. 
In a case-control approach, if there is an IBD-region that is only present in the 
case group, it is likely that the region contains a causative mutation 
(Albrechtsen et al., 2008). IBD mapping can have a very high power even with 
few individuals, under the assumption that there is a shared causative mutation 
present in the cases (Albrechtsen et al., 2008).  
 
When the mutation is known, it needs to be verified in other, independent 
individuals to make sure that the association holds up. This is usually done by 
genotyping the individuals for the SNP and performing a single-SNP 
association analysis. Single SNP testing can also be used for commercial 
testing. For example, if Mendelian SNPs for specific diseases have been 
identified it is possible to test animals before they are used for breeding, to 
verify whether or not they are carriers of a disease allele. There are several 
different techniques available for SNP genotyping, and they all, with a few 
exceptions, require the Polymerase Chain Reaction (PCR) step (Kim & Misra, 
2007). PCR is a technique that was developed for amplification of an 
organisms DNA or RNA. In the current thesis single SNP genotyping was 
performed in study I, II and IV using the TaqMan Real Time PCR assays from 
Thermo Fisher (Livak, 1999). Other methods that have been developed to 
genotype single SNPs are dynamic allele-specific hybridization (DASH) 
(Howell et al., 1999), molecular beacons (Tyagi & Russell Kramer, 1996), 
tetra-primer ARMS PCR (Ye et al., 2001), restriction fragment length 
polymorphism (RFLP) (Botstein et al., 1980) and pyrosequencing (Nordström 
et al., 2000).  
 
The association between a single SNP and a phenotype can be analyzed using 
different statistical methods. One method commonly used is linear models, 
which was used to analyze the data in study I. In study I the associations 
between DMRT3 genotype and different harness racing performance traits were 
analyzed. All traits were analyzed for associations with the mutation as well as 
a number of so-called covariates. For example for the trait earnings the 
covariates used in the model included number of starts, sex and birthdate. The 
covariates were included in the model to account for the variation in 
performance that may be due to factors other than the SNP of interest. For 
instance, if all horses with a certain genotype are stallions, chances are that 
those horses will have better performance records than the other genotypes, 
although the differences are mainly due to the difference in sex and not 
genotype.  
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1.9.3 Selective sweep mapping and Fst-analysis 
Selection in animals can be identified on a genetic level by so called selective 
sweeps in the genome. When there is selection for a specific allele in a 
population the variation for that SNP as well as the SNPs surrounding it will 
decrease, and eventually the alleles will become fixed. This will create regions 
in the genome with a high proportion of homozygosity (Maynard Smith & 
Haigh, 1974). These regions in the genome can be used to identify which parts 
of the genome are under selection in different breeds by performing a fixation 
index (Fst) analysis (Akey et al., 2009, Petersen et al., 2013, Ramey et al., 
2013). This was done in study IV in the current thesis where we compared the 
genomes of Coldblooded trotters, Standardbreds and the North-Swedish 
draught horses. Coldblooded trotters and North-Swedish draught horses share 
the same ancestor but the breeds have been selected for different purposes. 
While the North-Swedish draught horse is mainly used for heavy work, such as 
forestry and agricultural work, the Coldblooded trotters have developed into a 
pure racehorse breed.  
 
The aim of study IV was to identify regions under selection for performance, 
by comparing the Coldblooded trotters and North-Swedish draught horses with 
the racehorse breed Standardbreds. We calculated a sliding window Fst across 
the three breeds. The fixation index is a measure of how different two 
populations are based on the genetic structure. Fst was calculated for each SNP 
according to Wrights definition: Fst= var(p)/(p(1-p)), where p is the average 
minor allele frequency for the two breeds compared (Brown, 1970). The Fst 
value for each SNP varies between 0 and 1, 0 meaning that the allele 
frequencies of the two breeds compared are exactly the same and 1 meaning 
that the two breeds are fixed for opposite alleles. The average Fst value 
between two breeds gives an indication of the genetic relationship between the 
two breeds. An average Fst value of 0 between two breeds indicates that they 
are the same breed while 1 means that the two breeds are completely unrelated.  
 
In study IV in the current thesis the three breeds were divided into two sets, set 
A which included the Coldblooded trotters and the Standardbreds and set B 
which included all the Coldblooded trotters and the North-Swedish draught 
horses. The average Delta Fst was calculated from windows of five SNPs, by 
using ΔFst = Fst[Set B] - Fst[Set A]. The five top windows with the highest 
Delta Fst value, where the Fst for set A was low and the Fst for set B was high, 
were selected for further investigation. From each of the five regions the SNP 
with the highest single Fst value was selected for genotyping in additional 
horses. 
1.9.4 Whole-genome sequencing 
Whole-genome sequencing means that every single nucleotide in the genome is 
analyzed. This method produces large amounts of data for every individual. 
The first DNA sequencing was performed in the beginning of 1970 where a 
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small stretch of DNA was analyzed (Wu, 1970). Since then there has been a 
rapid development of new technologies and today it is possible to sequence the 
whole genome of any individuals, if the DNA analyzed is of acceptable 
quality. Sequencing analyses of ancient DNA (aDNA) is usually more 
complicated, due to degradation of the DNA (Nair, 2014). The first full 
genome to be sequenced was the genome of the bacteriophage φX174 in 1977 
(Sanger et al., 1977a). 
  
Before the introduction of whole-genome sequencing the most common 
sequencing method was the Sanger sequencing. The method was developed by 
Frederick Sanger and his colleagues in the end of the 1970s (Sanger & 
Coulson, 1975, Sanger et al., 1977b). The method is still used today, mainly 
for sequencing shorter pieces of DNA. However, for large scale DNA 
sequencing and whole genomes, the faster and more effective sequencing 
technology referred to as “Next-generation sequencing” (NGS) or “massively 
parallel sequencing” is used. The first commercially available platform for 
NGS analysis, GS 20, was developed in 2005 by 454 Life Sciences (Margulies 
et al., 2005). Today there are a number of different sequencing technologies 
available on the market (Goodwin et al., 2016, Mardis, 2017). The NGS 
technology can be used for analyzing different types of both DNA and RNA. 
With the introduction of a third generation of sequencing techniques, which is 
currently under development, it becomes possible to sequence individual 
molecules. These new methods also provide significantly longer reads than the 
previous techniques used (Bleidorn, 2016). 
 
Even though there are a number of different sequencing options and the cost 
for sequencing a genome has drastically decreased (Wetterstrand, 2015), it is 
still common to genotype individuals on SNP arrays instead, especially for 
studies that involve a large number of individuals. The main reasons for that 
are that even though sequencing provides more detailed information than SNP 
array it is still relatively expensive to whole-genome sequence many 
individuals. In addition, sequence data requires a large amount of storage and 
more computational analyses of the data.  
1.9.4.1 Sequencing of the horse genome 
A first draft of the horse genome sequence was completed in 2007 and shortly 
after a second version (EquCab2) was released (Wade et al., 2009). The horse 
sequenced was a Thoroughbred mare called Twilight. The size of the horse 
genome is about 2.7 Giga bases (Gb) and the predicted number of protein-
coding genes from EquCab 2 was 20,322 (Wade et al., 2009). About 1.2 
million SNPs were identified and a SNP map of more than one million markers 
was created using sequence data from seven horses of different breeds (Wade 
et al., 2009). Following the development of new technologies, especially in the 
field of NGS, a new updated version of the Equine genome (EquCab3) is now 
near completion (Kalbfleisch et al., 2017).  
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1.9.5 Functional genomics 
When a genetic variant has been verified to be associated with a specific 
phenotype the next step is often to study the function of the variant. The 
focuses of these studies are usually gene transcription, translation, gene 
expression and protein-protein interactions. Functional experiments can be 
performed on DNA or RNA level by modifying the gene or genetic region of 
interest and observing the effects on the phenotype. These kinds of studies are 
commonly referred to as functional genomic studies and encompass all 
research that aims to define the functions of genes in the genome (Gibson & 
Muse, 2009). Although the function of a protein in one species may differ from 
another species, the characterization of a protein in one species often gives a 
good idea about the function in other species (Gibson & Muse, 2009). There 
are three main approaches to study functional genetics on gene level: forward 
genetics, reverse genetics and fine-structure genetics (Gibson & Muse, 2009).  
The aim of the forward genetics approach is to identify which genes that affect 
a specific phenotype. This is done by inducing random mutations or looking at 
natural mutations in the genome of an organism, and then studying which 
phenotypes that are displayed. Based on the phenotype observed the work is 
focused on identifying the causative mutation (Gibson & Muse, 2009). The 
second approach, reverse genetics, has the DNA sequence as a starting point 
and aims to identify phenotypes that occur after disruption of one or several 
genes, so called knock-in or knock-out experiments (Gibson & Muse, 2009). 
The fine-structure genetics approach includes manipulation of the structure and 
regulation of specific genes, to characterize novel functions and interactions of 
the genes (Gibson & Muse, 2009).  
1.9.6 Transgenic animals and genome editing 
Using transgenic animals to study gene function is a common approach in 
today‟s genetic research. The phrase transgenic is used to describe the 
introduction of foreign DNA into the genome, including both the nuclear and 
the mitochondrial genome (Hickman-Davis & Davis, 2006, Pinkert, 2014). The 
first method to genetically modify animals was reported in the 1980´s (Wells, 
2010). Since then a number of different species, including mouse, rat, rabbit, 
pigs, sheep, goats and cattle have been genetically modified (Wells, 2010). 
 
There are different techniques used to create transgenic animals, including 
pronuclear injection, embryonic stem cell transfer, nuclear transfer, 
homologous recombination and RNA interference (RNAi) (Hickman-Davis & 
Davis, 2006, Pinkert, 2014). The basic procedure to create a transgenic mouse 
via embryonic stem cells includes the following steps: introduction of a 
transgene into stem cells derived from embryonic stem cell lines, injection of 
the modified stem cells into a host blastocyst and injection of the host 
blastocyst into a surrogate mother. The chimeric offspring can then reproduce 
and produce homozygous transgenic offspring (Gibson & Muse, 2009).  
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Genome editing is very similar to transgenic animals, with one major 
difference. While transgenic animals carry a foreign piece of DNA in their 
genome (Gibson & Muse, 2009), genome edited animals can be created by 
modifying, adding or deleting pieces of the individuals DNA. Genetic 
manipulation of animals is a useful tool in research. It can be used not only for 
studying gene function, but also to create animal models of human diseases, to 
improve resistance to disease and to treat inherited or spontaneous diseases 
(Wells, 2010). While the use of genome editing in larger animals such as pigs 
and cattle has so far been limited, it would be useful for human medical 
research and medicine, as for some traits these animals are more similar to 
humans compared to mice and rats (West & Gills, 2016). With the introduction 
of site-specific nucleases such as clustered regularly interspaced short 
palindromic repeats (CRISPR)/Cas9, it is now possible to edit the genome with 
more precision, to avoid problems with poor regulation of gene expression and 
variability associated with random integration (West & Gill, 2016). By 
changing the expression of different genes and studying the phenotype, it is 
possible to obtain an increased knowledge about which functions certain genes 
have. The use of genomically modified animals is also a powerful method to 
study gene function in living animals.  
1.10 Solving the puzzle 
Working with genetics is like solving a puzzle. Many small pieces are put 
together to create a bigger picture. To solve the genetic puzzle we need to use a 
combination of different approaches and methods. In the ideal scenario we start 
by testing for associations between a phenotype of interest and a large number 
of genotypes. We then genotype additional animals to verify the associations 
and we perform sequence analysis to narrow down the number of associated 
genetic variants. As a last step we perform functional studies to understand 
how the identified mutation/s influences the phenotype. Although it is 
important to remember that most studies do not fall into this category of ideal 
scenarios, all results obtained will add small but important pieces to the bigger 
puzzle. This will get us closer to solving the large and very complex picture of 
genetic regulation of different phenotypes. 
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2 Aims of the thesis 
This PhD project was divided into two parts. The overall aim of the first part 
was to present an investigation of the effect of the DMRT3 mutation in two 
different harness racing breeds. The overall aim of the second part was to 
identify novel genes influencing gaits and racing performance in horses.  
 
Specific aims of the thesis: 
 Investigate the importance of the DMRT3 mutation for early career 
performance in Coldblooded trotters 
 Determine the effect of the DMRT3 mutation on harness racing 
performance at different ages in a large sample of raced and unraced 
Coldblooded trotters 
 Investigate the effect of the DMRT3 mutation on racing performance 
and riding ability traits in Finnhorses 
 Compare four- and five-gaited Icelandic horses with the same DMRT3 
genotype to identify novel genes influencing pacing ability 
 Compare the genomes of Standardbreds, Coldblooded trotters and 
North-Swedish draught horses to identify novel genes important for 
harness racing performance 
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3 Summary of studies (I-IV) 
This thesis comprises four studies (I-IV) with the aim to investigate the genetic 
regulation of horse performance and locomotion pattern. Studies I-II were 
performed to evaluate the effect of the DMRT3 gene on harness racing 
performance in Coldblooded trotters and Finnhorses. In the third study (III) we 
compared four- and five-gaited Icelandic horses with the same DMRT3 
genotype in order to identify novel genetic factors influencing pacing ability. 
The last study (IV) compared the genomes of Coldblooded trotters, North-
Swedish draught horses and Standardbreds, with the aim of identifying novel 
genes important for harness racing performance.   
3.1 Study I – Lack of significant associations with early career 
performance suggest no link between the DMRT3 “Gait 
Keeper” mutation and precocity in Coldblooded trotters 
To investigate the effect of the DMRT3 mutation on harness racing 
performance in Swedish-Norwegian Coldblooded trotters, 770 raced (n=485) 
and unraced (n=285) horses were genotyped for the DMRT3 SNP. The horses 
were born between the years 2000 and 2009. We analyzed racing performance 
data for the years 2003 to 2015. Three age intervals were defined, 3, 3-6, and 
7-10 years of age, and included in the performance analyses. The performance 
traits analyzed in the study included number and frequency of wins and 
placings (1-3), earnings and race times, as well as how many times the horse 
had been disqualified for galloping. In the study we also compared the DMRT3 
genotype frequencies between raced and unraced horses. 
3.1.1 Results and discussion 
Most of the performance results at 3 years of age did not differ significantly 
between genotypes and there were no differences in how many of the horses 
that started to compete at that age. The average age for the first start did not 
differ between the genotypes. However, there was a significant difference in 
the frequency of the AA genotype between raced and unraced horses (Figure 
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5). Only 45 % of the AA horses raced compared to 68 % of the CA horses and 
63 % of the CC horses. 
 
 
Figure 5. DMRT3 genotype frequency in raced and unraced Coldblooded 
trotters 
 
At older ages, the CA horses performed significantly better than the CC horses 
for almost all traits but there were no significant differences between CA and 
AA horses for the ages 3 to 6 years (Table 1). Despite the higher number of 
placings for the AA horses compared to the CC horses, they earned less money 
(Table 1). Interestingly, for the age interval 7 to 10 years there was a 
significant difference in number of starts between the genotypes, with AA 
horses starting less often. This suggests that the AA horses end their career 
earlier than horses with the other genotypes. Also, the AA horses that did 
compete at those ages had the lowest number of placings and earnings. The 
findings suggest that the AA genotype is not as advantageous for performance 
in Coldblooded trotters as it is for Standardbreds and Finnhorses, especially 
since the ability to start racing is one of the most important traits for a 
successful racehorse. 
 
For all age intervals studied, the CC horses had the highest number of 
disqualifications. This finding is in concordance with a previous study on 
trotting technique in Coldblooded trotters where the CC horses had more 
problems to coordinate their trot, compared to CA and AA horses (Jäderkvist et 
al., 2014). The low starting frequency for the AA horses may also be 
influenced by trotting technique, as a previous study reported an increased 
preference for the unwanted gait pace in AA Coldblooded trotters (Jäderkvist 
et al., 2014). Overall, the most desirable DMRT3 genotype in Coldblooded 
trotters appears to be the heterozygous CA, which is different from the 
situation in both Standardbreds and Finnhorses (Andersson et al., 2012, 
Jäderkvist et al., 2014, Jäderkvist Fegraeus et al., 2015). If the AA 
Coldblooded trotters are more precocious than the other genotypes, as was 
suggested in the previous study (Jäderkvist et al., 2014), we would have 
expected a higher proportion of AA horses racing at 3 years of age as the desire 
for precocious Coldblooded trotters is strong. Although the starting frequency 
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for the AA horses was low, the AA horses that made it to the racetrack 
performed well up to six years of age, as indicated by high median values for 
earnings and victories. While successful at young ages, the AA horses did not 
perform as well for the older ages, where the median values for earnings and 
victories were the lowest of the three genotypes. 
 
Overall the results demonstrate the importance of studying different breeds to 
fully understand the effects of specific genes. The study also provides valuable 
knowledge for the Coldblooded trotter industry on what effect the DMRT3 
gene has in the breed.  
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Table 1. Mean and median racing performance results for Coldblooded trotters at 3 to 6 years of age according to DMRT3 
genotype 
 AA (n=26-41) CA (n=149-243) CC (n=99-188) P-value2 
Trait1 Mean Median SE Mean Median SE Mean Median SE AA/CA CA/CC AA/CC 
No.of starts 23.4 18.0 2.7 26.4 23.0 1.3 23.0 18.0 1.3 0.27 0.002 0.89 
No of wins 2.9 2.0 0.5 3.3 2.0 0.3 2.6 1.0 10.3 0.95 0.007 0.11 
Wins (freq.) 0.126 0.111 0.020 0.111 0.080 0.008 0.088 0.054 0.008 0.68 0.11 0.13 
No of placings (1-3) 8.2 8.0 1.0 8.8 6.0 0.6 7.0 4.0 0.6 0.93 <0.001 0.007 
Placings (freq.) 0.323 0.329 0.031 0.298 0.286 0.013 0.243 0.225 0.014 0.70 0.005 0.03 
No of unplaced 11.0 7.0 1.5 12.0 11.0 0.6 11.0 9.0 0.6 0.31 0.004 0.93 
Unplaced (freq.) 0.499 0.471 0.034 0.480 0.462 0.014 0.490 0.500 0.016 0.84 0.88 0.96 
No of 
disqualifications 
1.8 1.0 0.4 2.7 2.0 0.2 3.5 3.0 0.3 0.24 0.04 0.007 
Disqualifications 
(freq.) 
0.111 0.043 0.024 0.142 0.100 0.013 0.229 0.188 0.019 0.65 <0.001 0.003 
Earnings (SEK) 128,100 98,500 20,625 179,300 72,500 18,543 133,200 54,370 17,154 0.72 <0.001 0.03 
Earnings/start (SEK) 4,963 3,895 594 5,417 3,781 428 4,178 2,873 355 1.00 0.007 0.19 
Race time auto 
(sec/km) 
89.1 88.9 0.4 89.5 88.8 0.5 89.9 89.8 0.3 0.76 0.002 0.39 
Race time volt 
(sec/km) 
91.1 90.0 0.7 91.2 90.7 0.3 91.9 91.8 0.3 0.86 0.005 0.06 
1 Transformed values were used for the analysis: log10, ln(earnings + 1 000) and ln(race time - 68.2) 
2 A multiple comparison test was performed using Tukey´s HSD test. Significant results (P≤0.05) in bold 
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3.2 Study II – Different DMRT3 genotypes are best adapted for 
harness racing and riding in Finnhorses  
In Study II we investigated the effect of DMRT3 genotype on harness racing 
performance and riding traits in Finnhorses. One-hundred and eighty 
Finnhorses used for harness racing and 59 Finnhorses used for riding were 
genotyped for the DMRT3 mutation. The trotters were born between 1999 and 
2010 and the riding horses were born between 1991 and 2011. All harness 
racing horses had competed at least once. The racing performance traits 
analyzed included number of starts, wins and placings, as well as earnings and 
race times. Associations between DMRT3 genotype and the performance traits 
were analyzed for three age intervals: 3, 3-6 and 3-10 years of age. Data for the 
riding horses were collected via an owner-questionnaire, where the rhythm, 
balance and transitions for each gait were scored on a scale from 1 (poor) to 6 
(perfect). The questionnaire also included additional questions about the gaits 
of the horse as well as competition experience.  
3.2.1 Results and discussion 
The frequency of the A-allele was significantly higher in Finnhorses used for 
harness racing compared to the horses used for riding (Table 2).  
 
Table 2. Allele frequencies in trotting and riding Finnhorses 
Finnhorse type n A C P-value
1
 
Harness racing 180 0.63 0.37  
Riding  59 0.43 0.57  
Total 239 0.58 0.42 <0.001 
1Fisher´s exact test was performed in R 
3.2.1.1 Harness racing performance 
At 3 years of age there were only two genotypes present, CA and AA, and 
there were no significant differences in performance between the two groups. 
Only 25 out of 180 horses (14%) started their racing career at 3 years of age 
and most horses started to compete at 4 years of age. There were no differences 
observed between the genotypes for age at first start. For the older ages, 3 to 6 
and 3 to 10 years of age, the AA horses performed significantly better than the 
C-horses, with more wins and placings, higher earnings and faster race times 
(Table 3). 
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Table 3. Average racing performance results for Finnhorses for the age period 
3 to 6 years (standard errors in brackets) 
Performance trait AA (n=41-52) CA (n=60-83) CC (n=13-19) P-value1 
No. of starts 21.7 (1.8) 26.9 (1.9) 24.2 (3.3) 0.23 
Wins (freq.) 0.234 (0.030) 0.116 (0.013) 0.061 (0.013) <0.001 
Placings (freq.) 0.464 (0.032) 0.324 (0.020) 0.217 (0.025) <0.001 
Earnings (euro)2 20,659 (4216) 11,411 (1695) 4,026 (1155) 0.009 
Time rec. volt2,3 89.9 (0.6) 91.5 (0.6) 92.9 (0.8) 0.005 
Time rec. auto2,3 88.4 (0.7) 89.2 (0.5) 91.9 (0.9) 0.006 
1A Wald test was performed in PLINK, significant values in bold 
2For these variables transformed values were used for the calculations: ln(earnings+100), 
ln(time record-68.2) 
3Best average race time for 1 kilometer, in seconds  
 
3.2.1.2 Riding performance traits 
For the riding performance traits the CA and CC horses got significantly better 
scores than the AA horses for most of the traits analyzed. While the gait scores 
for the AA horses differed significantly from the C-horses, there was only one 
significant difference between CA and CC horses (rhythm in extended canter, 
P=0.05) (Table 4).  
 
Table 4. Average gait scores for Finnhorses with different DMRT3 genotypes 
Trait1 AA CA  CC P-value2 
 n=13-14 n=22-23 n=22 AA/CA AA/CC CA/CC 
Coll. canter       
 Rhythm 2.50 (0.31) 4.57 (0.22) 4.23 (0.26) <0.001 <0.001 0.32 
 Balance 2.71 (0.38) 4.30 (0.25) 4.14 (0.25) <0.001 0.003 0.63 
 Transitions 2.57 (0.36) 4.04 (0.26) 3.82 (0.25) 0.002 0.006 0.53 
Ext. canter       
 Rhythm 2.71 (0.30) 4.52 (0.23) 3.82 (0.26) <0.001 0.01 0.05 
 Balance 2.79 (0.37) 4.09 (0.27) 3.91 (0.26) 0.007 0.02 0.64 
 Transitions 2.64 (0.36) 3.87 (0.25) 3.64 (0.22) 0.007 0.02 0.50 
Coll. trot       
 Rhythm  2.38 (0.29) 4.34 (0.24) 4.41 (0.21) <0.001 <0.001 0.83 
 Balance 2.38 (0.29) 4.43 (0.20) 4.55 (0.19) <0.001 <0.001 0.68 
 Transitions 2.38 (0.27) 4.30 (0.20) 4.45 (0.18) <0.001 <0.001 0.57 
Ext. trot       
 Rhythm 2.85 (0.32) 4.09 (0.24) 3.68 (0.26) 0.003 0.05 0.25 
 Balance 2.85 (0.41) 3.95 (0.25) 3.73 (0.24) 0.02 0.05 0.52 
 Transitions 2.77 (0.39) 3.95 (0.26) 3.64 (0.24) 0.01 0.06 0.38 
Walk       
 Rhythm 4.00 (0.30) 4.91 (0.21) 4.50(0.18) 0.02 0.14 0.15 
 Balance 4.08 (0.33) 4.95 (0.17) 4.68 (0.22) 0.01 0.12 0.33 
 Transitions 3.85 (0.34) 4.77 (0.19) 4.55 (0.23) 0.01 0.08 0.44 
Jumping ability 3.54 (0.37) 4.13 (0.28) 4.32 (0.25) 0.22 0.08 0.62 
1 Scale from 1 (poor) to 6 (perfect) 
2 Pairwise comparisons were made using Student´s t-test, significant values are in bold 
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This study is a good example of how DMRT3 influences different traits in the 
breed. As previously demonstrated the frequency of the CC genotype is high 
in breeds used for traditional riding, suggesting that the genotype is favorable 
for the ability to canter (Jäderkvist et al., 2015, Promerová et al., 2014, 
Jäderkvist et al., 2015). Even though the Finnhorses used for riding and 
harness racing are all considered to be the same breed, this study 
demonstrated a clear difference in genotype frequency between the two 
groups. While AA was the most favorable genotype for harness racing, riding 
horses with the AA genotype received poor evaluation scores for the riding 
ability traits. In the future these results may be used in the breeding process 
and the selection of horses for the different disciplines. Given the strong 
association between DMRT3 and gaits and performance in Finnhorses the 
difference in genotype frequency between riding and trotting horses will 
likely be even bigger in the future than it is today.  
 
It is interesting to note that even though Finnhorses and Coldblooded trotters 
are very similar phenotypically, the effect of the DMRT3 mutation is clearly 
different. While the exact reasons for this are still unknown, one could 
speculate that it may be due to different training strategies or conformation 
differences. In studies I and II we observed a difference between the breeds 
for when the horses started their first race. While most Finnhorses start to race 
when they are four years old, most Coldblooded trotters start competing 
already at three years of age. This means that the Finnhorses have more time 
for training before they start to race, and this may have an influence on the 
risk for injuries. One of the theories for the low number of starts for AA 
Coldblooded trotters is that they are very talented and can run very fast early 
in life. This early speed training may increase the risk for injuries. If the 
Coldblooded horses started to compete one year later maybe the performance 
results would look different.  
3.3 Study III - To pace or not to pace: a pilot study of four- and 
five-gaited Icelandic horses homozygous for the DMRT3 
“Gait Keeper” mutation  
As previously mentioned, the DMRT3 mutation appears to be required for 
pacing ability in horses. However, even though homozygozity for the mutation 
is required, only about 70% of the AA Icelandic horses are reported to pace 
(Andersson et al., 2012, Jäderkvist et al., 2015). Therefore in Study III we 
performed a genome-wide scan and compared four- and five-gaited Icelandic 
horses with the DMRT3 genotype AA, to investigate whether there are other 
genetic factors involved in the regulation of pace. An owner questionnaire was 
used to determine the gait preferences of the horses. To obtain as many four-
gaited AA horses as possible and avoid getting four-gaited CA horses, we 
advertised online for four-gaited horses with two five-gaited parents. The 
horses were selected based on the results from the questionnaire. All horses 
44  
were genotyped for the DMRT3 mutation and any CA horses were excluded 
from the study. After genotyping of DMRT3 55 horses (20 four-gaited, 35 five-
gaited) born between 1986 and 2010 remained and were included in the study. 
The horses were genotyped for 670,000 SNPs using the 670K Axiom Equine 
Genotyping Array. A genome-wide association (GWA) analysis of the gaits 
(four- or five-gaited, 0/1) was performed using a principal component approach 
(“egscore” function) (PCA).  
3.3.1 Results and discussion 
The genotyping failed in one individual and after quality control (QC) 54 
individuals (19 four-gaited, 35 five-gaited) were analyzed for 356,741 SNPs. 
No SNPs demonstrated significant associations with the ability to pace (Figure 
6). However, one region on chromosome 6 showed a suggestive association. 
There were two closely located SNPs that resulted in the lowest P-values 
(Table 5). These SNPs were located close to the glutamate ionotropic receptor 
NMDA type subunit 2B (Grin2B) gene (chr6. 41,227,875-41,626,797) (Wade 
et al., 2009). As demonstrated in Figure 6 one SNP on chromosome 34 also 
showed a suggestive association with the trait. As horses only have 32 
chromosomes pairs, in the GWA analysis chromosome 34 was classified as 
unknown chromosome.  
 
 
Figure 6. Manhattan plot for the comparison of four- and five gaited Icelandic 
horses homozygous for the DMRT3 mutation (AA). The red line indicates the 
Bonferroni-corrected significance threshold (P<1.4x10
-7
); the black line 
indicates the threshold for suggested genome-wide significance (P<1x10
-5
) 
45 
 
Table 5. Top 10 SNPs from the GWAS analysis  
SNP Name Chromoso
me 
Position P-value 
unadjusted 
P-value 
adjusted (genome-wide)* 
AX-104875752 6 41,206,762 4.6x10
-7
 0.29 
AX-104542743 6 41,218,272 4.6x10
-7
 0.29 
AX-103922132 und 17,547,779 4.6x10
-7
 0.29 
AX-103516804 29 1,112,0750 1.7x10
-6
 0.68 
AX-103497403 29 11,151,705 1.7x10
-6
 0.68 
AX-104844167 6 41,292,483 3.5x10
-6
 0.86 
AX-104841069 24 2,138,716 5.7x10
-6
 0.93 
AX-104349116 X 55,026,040 7.2x10
-6
 0.96 
AX-103477519 5 89,752,224 7.4x10
-6
 0.96 
AX-104225161 5 89,794,839 7.4x10
-6
 0.96 
*After 10,000 permutations 
 
Although limited by the small sample material, the findings from Study III may 
warrant further investigation, as the Grin2b gene is involved in neural 
regulations in mice and humans and the gene is considered to be an important 
factor for learning and memory (Tang et al.,1999, Zamanillo et al., 1999). In 
addition to the GWA analysis we also calculated the chip heritability for pace 
(i.e. how much of the variation observed is explained by all the genotyped 
SNPs combined). The heritability for pace previously reported is 0.6-0.7 
(Albertsdóttir et al., 2011). The chip heritability estimate in the current study 
was considerably lower (0.18) and this supports the theory that most of the 
variation in pace is explained by DMRT3. However, it also provides evidence 
that there are other genetic factors, in addition to DMRT3, that determines 
whether a horse can pace or not. Future studies will benefit from including not 
only horses that have never paced, but also horses that are more difficult to get 
to pace and that prefer other gaits. Likely, the genetic regulation of pace in 
addition to DMRT3 is complex and involves factors such as conformation and 
willingness of the horse.  
3.4 Study IV – Selective sweep mapping using a unique Nordic 
horse model revealed EDN3 as a candidate gene for 
harness racing performance 
With the aim to identify novel genes important for harness racing in study IV 
we performed an introgression study. Here we utilized the close relationship 
between the Coldblooded trotter and the North-Swedish draught horse and the 
fact that Coldblooded trotters have long been selected for harness racing 
performance (Bohlin & Rönningen, 1975). In addition, it is well known that 
before parentage testing was introduced in the breed in 1969, Coldblooded 
trotters were crossbred with Standardbreds to improve the racing performance. 
Study IV includes a Delta-Fst analysis, combined with a performance 
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association analysis in 400 Coldblooded trotters to identify regions that have 
been selected for performance. 
 
For the first part of the study we obtained blood samples from 11 Coldblooded 
trotters, 19 North-Swedish draught horses and 12 Standardbreds, in total 42 
horses. The draught horses were all approved breeding stallions and the trotters 
were elite-performing horses selected based on EBV and pedigree. DNA was 
extracted and the samples were genotyped on one of two different Illumina 
SNP50 Genotyping BeadChips. After merging the data it was divided into two 
sets to be used for the calculation of Fst between the breeds: Set A included all 
the Coldblooded trotters and Standardbreds and Set B included all the 
Coldblooded trotters and the North-Swedish draught horses.  
 
The association between each SNP and harness racing performance was 
investigated in 400 Coldblooded trotters using linear models. If there were any 
significant associations between a SNP and performance we also performed 
haplotype analysis for that region. In addition to the performance association 
analyses we genotyped 1,634 horses of different breeds for the top SNP 
identified in the Delta-Fst analysis.  
3.4.1 Results and discussion  
The Delta Fst-analysis provided five regions on different chromosomes where 
the Standardbreds and Coldblooded trotters were genetically similar but 
together differed from the North-Swedish draught horse (Table 6). From the 
five SNPs tested for association with racing performance, only one appeared to 
have a significant impact on the performance traits analyzed (g.22: 
45748491C>T), and the CC genotype seemed to be negatively associated with 
the majority of traits (Table 7). Also, four SNPs in high LD with the associated 
SNP (r
2
 = 0.92-0.94) were significantly associated with racing performance.  
 
Table 6. Five top-regions from the Delta Fst analysis 
Chr. SNP window (bp) Delta Fst value 
(window of 5 
SNPs) 
Z-
transformed 
Delta Fst 
SNP for 
association 
analysis (bp) 
22 45,748,491- 45,752,522 0.34 5.67 45,748,491 
7 67,498,458-67,594,705 0.33 5.41 67,498,458 
10 49,931,991-50,002,425 0.30 5.09 49,931,991 
15 88,492,813-88,577,552 0.27 4.61 88,565,665 
11 2,153,152-2,521,729 0.25 4.37 2,517,091 
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Table 7. Coldblooded trotter performance results for SNP g.22:45748491C>T 
Genotype TT (n=106-173) TC (n=112-167) CC (n=15-38) P-values2 
Performance trait1 Mean Median Mean Median Mean Median TT vs TC TT vs CC TC vs CC 
No. of starts 37.6 29.0 37.7 26.0 23.1 18.0 0.94 0.01 0.02 
No. of wins 4.1 2.0 4.1 2.0 1.9 1.0 0.72 0.006 0.01 
No. of placings (1-3) 11.1 6.0 11.5 7.0 6.0 3.0 0.08 0.10 0.007 
Wins (freq.) 0.10 0.07 0.09 0.07 0.06 0.02 0.28 0.84 0.39 
Placings (freq.) 0.24 0.23 0.28 0.27 0.20 0.16 0.46 0.66 0.38 
Earnings (SEK)3 235,900 81,000 249,300 102,200 97,280 42,290 0.12 0.27 0.04 
Earnings/start (SEK) 3 4,734 3,152 4,965 3,917 3,108 2,332 0.21 0.02 0.003 
Time record voltstart (sec/km) 90.8 90.4 90.5 90.0 92.6 91.8 0.09 0.15 0.01 
Time record autostart (sec/km) 88.8 88.6 88.8 88.6 90.2 90.4 0.95 0.31 0.33 
1) Transformed values were used for the analysis: log10, ln(earnings + 1 000) and ln(race time - 68.2) 
2) Linear model analyses were performed in R. Significant results (P≤0.05) in bold 
3) SEK=Swedish Kronor 
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For the top-region on ECA 22 we also performed haplotype analysis using 7 
SNPs, including the 5 significant SNPs observed in the single SNP association 
analysis. There were four haplotypes present in the population: TGTAAAG, 
GGTAAAA, TTCGGGA and GTCGGGG, with the SNP identified in the 
Delta-Fst analysis on position 3. The TGTAAAG haplotype was the most 
common (0.34) and it was nominated as the base haplotype. We observed a 
significant effect of the haplotype TTCGGGA on the number of starts and 
number of victories (P ≤ 0.05). Apart from that, none of the haplotypes showed 
any significant associations with racing performance.  
 
When genotyping additional breeds for the top SNP we observed a high 
frequency of the TT genotype in breeds considered to be high-performing, i.e. 
Standardbreds, Coldblooded trotters, Finnhorses, Thoroughbreds and 
Warmbloods. On the other hand, the frequency of the CC genotype was high in 
North-Swedish draught horses, Exmoor, Shetland ponies, Gotlandsruss and 
Icelandic horses (Table 8).  
 
Table 8. Genotype frequencies for SNP g.22:45748491C>T in 14 different 
breeds 
Breed TT  TC CC  n 
American Curly 
Ardennes 
0.84 
0.00  
0.15 
0.00  
0.01 
1.00 
87 
7 
Thoroughbred 0.99  0.00  0.01 91 
Finnhorse 0.37  0.47  0.16 157 
Fjordhorse 0.00  0.00  1.00 20 
Gotlandsruss 0.07  0.25  0.69 153 
Icelandic horse 0.05  0.42  0.53 167 
Swedish Warmblood 0.94  0.05  0.01 77 
Coldblooded trotter 0.46  0.47  0.07 183 
North-Swedish draught horse 0.02  0.15  0.83 53 
Standardbred 0.73  0.25 0.02 250 
Shetland- and minishetland 0.18  0.47 0.35 104 
Exmoor 0.00  0.03 0.97 271 
American Miniature 0.29  0.64 0.07 14 
 
The top region identified on ECA 22 was located close to the gene Endothelin3 
(EDN3). The EDN3 gene encodes for a ligand that binds to an endothelin 
receptor (Baynash et al., 1994, Hosoda et al., 1994). The gene is mostly known 
for its impact on the development of melanocytes and enteric neurons and no 
previous studies have reported any associations between mutations in the gene 
and performance (Baynash et al., 1994, Hosoda et al., 1994, Lee et al., 2003, 
Stanchina et al., 2006). However, there have been reports of associations 
between the EDN3 gene and high blood pressure and cardiovascular disease 
risk in humans (Levy et al., 2009, International Consortium for Blood Pressure 
Genome-Wide Association Studies, 2011). This, and the fact that the gene is 
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involved in the regulation of vasopressin release from the hypothalamus, could 
be a possible explanation for the association observed in the current study 
(McKeever et al., 2002). Also, another type of endothelin, EDN1 may be of 
importance for performance. One study observed an increase in the 
concentration of the EDN1 protein after exercise in horses, and another study 
suggested a possible association of EDN1 and asthma in horses (Benamou et 
al., 1998, McKeever et al., 2002). Except for the region close to EDN3 no 
other regions associated with performance were identified in the Delta Fst 
analysis and none of the already known performance genes were detected in 
the top regions (Binns et al., 2010, Gu et al., 2010, Hill et al., 2010a, 
Andersson et al., 2012, Thomas et al., 2014). The reasons for lack of 
significant associations may be that Delta Fst analysis detected genes important 
for other traits than performance, the small sample size used for the Fst 
estimation, low genetic variation for the SNPs analyzed or the low number of 
SNPs used in the analysis. Also, the Fst analysis was performed for windows 
of five SNPs and it is possible that single SNPs with a high Fst value were not 
discovered because the other SNPs in the same window had a low Fst value. In 
addition, it is also possible that some SNPs were not discovered because the 
allele frequencies differ between all three breeds. One example is the DMRT3 
nonsense mutation, where North-Swedish draught horses and Standardbreds 
were more or less fixed for the opposite alleles. However, the majority of the 
Coldblooded trotters were heterozygous. For that reason the gene was not 
discovered in the top regions in the Delta Fst analysis, although we know that 
the gene is important for harness racing performance. This may be the situation 
also for other SNPs.  
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4 Concluding remarks, future prospects 
and practical applications 
 
 
In this thesis we have investigated the genetics behind locomotion pattern and 
performance in horses. We demonstrated a significant effect of the DMRT3 
mutation on harness racing performance in two different breeds and we also 
discovered novel potential candidate genes for locomotion pattern and harness 
racing performance. While the ability to pace appears to be mainly controlled 
by the DMRT3 mutation, clearly other genes influence the trait. As 
demonstrated in this thesis the genetic background of pacing ability and 
harness racing performance is complex, with several genes involved in the 
regulation of these traits. Identification of a major gene for a complex trait, like 
DMRT3, is probably a rare event, as most traits are affected by a large number 
of genes with small effects. Mapping the genetic regulation of complex traits is 
far more challenging than for a monogenic trait, as there may be hundreds or 
even thousands of genes with small effects that control a complex trait. In 
addition, the environment will have an effect on the trait. Nevertheless, 
knowledge about the genetics of complex traits is still crucial for genetic 
applications in agriculture and human medicine.   
 
The results from study I and II provided information about the DMRT3 gene 
and the effect in different breeds. As there is a genetic test available for the 
DMRT3 mutation the information and knowledge gained from these studies 
will be an aid in the selection process and breeding of these horses. Also, it is a 
useful tool for planning the training of the horses, as some horses may require 
more extensive training before they are ready to compete while others need to 
be more carefully trained to avoid injuries. In study III we identified a potential 
candidate gene for pacing ability in horses. Interestingly, the SNP was located 
close to a gene that is known to be an important factor for memory and 
learning ability. Possibly the ability to pace is influenced by a horse´s ability to 
learn new tasks. This finding would be interesting to follow up in additional 
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horses to confirm whether or not some horses have a genetic variant that makes 
it easier for them to learn new things. The study included four-gaited Icelandic 
horses homozygous mutant for DMRT3 that had never showed any signs of 
pace and these horses were compared with five-gaited AA Icelandic horses that 
were natural pacers. Any four-gaited horse that had showed signs of pace, even 
if it was just one time, were excluded. As no SNPs reached genome-wide 
significance, in the future it would be interesting to also include horses that 
have shown pace, but that were more difficult to teach to pace, or horses that 
just showed pace a few times. One way could be to compare Icelandic horses 
that are homozygous AA and evaluated for breeding as four- respectively five-
gaited. Horses with limited pacing ability are often not trained in pace as the 
training may impair the quality of the tölt. As such, some of the horses 
evaluated as four-gaited may have the ability to pace, but they are not trained 
for it. Including Icelandic horses with limited pacing ability in the analysis 
would also make it possible to increase the sample size and thereby increase 
the statistical power. It would also be interesting to study pacing ability in 
other breeds, for example the Coldblooded trotters. There are some AA 
Coldblooded trotters that have a lot of problems with pace, while other AA 
Coldblooded trotters only trot. Comparing these two groups would provide 
additional information about which genes control pacing ability. 
 
In study IV we utilized SNP array data to identify selective sweeps for 
performance in Coldblooded trotters. To continue the search for new 
performance genes we have obtained pooled whole-genome sequence data 
from Coldblooded trotters, Standardbreds and North-Swedish draught horses. 
We will perform the same type of Delta Fst analysis in this data set to 
hopefully confirm the findings in study IV and perhaps also identify additional 
regions that may be of importance for performance. To follow up the 
associations found between the EDN3 gene and racing performance we will 
perform functional experiments to investigate the role of this gene in horses. 
Our group is a member of the Functional Annotation of Animal Genomes 
(FAANG) consortium (www.faang.org). The aim of the FAANG project is to 
create an infrastructure that can be used to improve the fundamental 
understanding of biology and better understand the link between genotype and 
phenotype. Another aim of FAANG is to provide high quality functional 
annotation of the animal genomes. Through the FAANG project we will have 
access to various types of gene expression and epigenetic data that we can use 
in our studies, for example through the “adopt a tissue” initiative. With the help 
of equine researchers all over the world, a large number of horse tissues have 
been sequenced (RNA) to provide an atlas for the horse research community. 
By funding the sequencing of several tissues the research group will get access 
to the raw sequence files as soon as they are available. In addition, the funding 
will also assist in creating a better atlas of RNA sequences from various tissues 
to be used by the whole horse genome community.  
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The optimal racehorse should have a correct conformation, willingness to run 
fast, be resistant to diseases and injuries, it should mature early in life and it 
should be durable. For some of these traits a large fraction of the phenotype is 
controlled by genetics. As such, even though we know about a handful of 
genes that influence horse performance, there is much more left to discover. 
Therefore, our future studies will not focus as much on the already known 
performance genes, but more on the discovery of novel genes influencing 
performance in horses. This will be done using both selective sweep mapping 
and performing GWA analyses for performance traits in different breeds. 
Currently, GWA analyses are being conducted for performance traits in 
Coldblooded trotters and this project also includes an investigation of the 
genetic diversity of the breed. In addition, we aim to continue to work with the 
genetics of gaits and locomotion pattern in different breeds by for instance 
studying horses with the same DMRT3 genotype but with different gait pattern. 
Further studies of the quality of the gaits would be interesting to perform, to 
understand more about the genetic regulation of locomotion pattern in 
mammals.  
 
While the DMRT3 gene clearly is important for the development of a normal 
locomotor network in mammals, the exact functions of the gene are still 
unknown. To better understand the role of the gene in the regulation of 
neuronal development it is necessary to study which genes that DMRT3 binds 
to and which genes that bind to and regulate the expression of DMRT3. Also, 
although the gene has major impacts on locomotion pattern and performance in 
horses, it is very important to remember that the gene is only one part of the 
big puzzle. It is easy to create misleading selection in a breed if the results 
from the research are not correctly interpreted. Therefore, it is important that 
the industry is provided with correct information from the researchers on what 
is found and how the results should be interpreted and used.  
 
To summarize, this thesis has confirmed the importance of the DMRT3 gene 
for locomotion pattern and harness racing performance and it also showed that 
many other factors are important for which gaits a horse can perform or how 
fast they can run on the racetrack. The search for novel genes will continue 
with the aim to add more knowledge to the big and complex genetic puzzle 
underlying racing performance and locomotion pattern.  
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5 Sammanfattning 
På grund av sin atletiska natur och det stora antalet olika hästraser är hästen 
är en utmärkt genetisk modell för att studera rörelsemönster och gångarter hos 
däggdjur. Hos många hästraser är rörelser och förmågan att trava eller 
galoppera i högt tempo högt värderade egenskaper. Målet med denna 
avhandling var att få en bättre förståelse för genetiken som påverkar gångarter 
och prestation hos hästar. Avhandlingen består av fyra artiklar som behandlar 
fyra olika hästraser. I artikel I och II beskrivs effekten av en känd mutation i 
genen doublesex and mab-3 related transcription factor3 (DMRT3) på 
prestationsegenskaper hos svensk-norska kallblodstravare och Finnhästar. 
Tidigare studier har visat en stor effekt av genen på prestation hos 
varmblodstravare. Resultaten från studie I och II visade att även om genen är 
viktig för prestation hos både kallblodstravare och Finnhästar så skiljer sig den 
mest framgångsrika genotypen mellan raserna. Finnhästar som är homozygota 
för mutationen (AA) var mer framgångsrika på travbanan men hade en sämre 
galoppförmåga som ridhästar. För kallbloden så presterade CA hästarna bättre 
överlag, även om AA hästarna presterade bra som unghästar.  
Tidigare studier har rapporterat att en häst måste vara homozygot för 
DMRT3 mutationen för att kunna gå i passgång. Trots detta kan inte alla AA 
hästar gå i pass. För att försöka förstå mer om den genetiska regleringen av 
passgång hos hästar har vi i studie III jämfört genomet hos islandshästar som är 
homozygota (AA) för DMRT3 mutationen men med eller utan förmåga att gå i 
passgång. Vi genomförde en genomisk associationsstudie och identifierade en 
potentiell kandidatregion som innehöll en gen som är känd för att påverka 
minne och inlärning hos andra arter. 
I studie IV utnyttjade vi det nära släktskap som finns mellan den svensk-
norska kallblodstravaren och den nordsvenska brukshästen för att identifiera 
nya gener som påverkar prestationsförmåga. De två raserna är genetiskt lika 
men har selekterats för olika egenskaper. Genom att jämföra genomet hos de 
två raserna med genomet hos varmblodstravare kunde vi identifiera fem topp-
regioner där kallblodstravarna och varmblodstravarna var lika genetiskt men 
skiljde sig från den nordsvenska brukshästen. En av regionerna innehöll fem 
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enbaspolymorfier (SNPs) som alla var signifikant associerade med prestation 
hos kallblodstravare.  
Sammanfattningsvis visar vår forskning att noga utvalda hästmaterial kan 
fungera som modeller för att få en djupare kunskap om genetiken bakom 
prestation och rörelsemönster och att det är nödvändigt att studera betydelsen 
av dessa gener hos olika hästraser.   
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